COVID-19

What is the value in acknowledging the problem of people dying and then not intervening to fix it? The lives of these patients are all valuable - more valuable than this process might suggest. They deserve to be treated with respect and not denied their right to human dignity while the government negotiates a good deal for itself.

By the time CARVYKTI is available through the NHRA, it will have been over two years since Health Minister Mark Butler acknowledged the relationship between time-to-funded access and preventable deaths.

The Pharmaceutical Benefits Advisory Committee delivered recommendations at its December meeitng for mental health and paediatric immune conditions.

"Today’s announcement is a positive step towards affordable and equitable access to a potentially life-saving lung cancer treatment for those patients in real need,” said Christine Cockburn, the CEO of Rare Cancers Australia.

Although the pandemic ended over two years ago, the more we learn about what happened, the more we need the promised Royal Commission.

The Rare Cancers Australia 2025 Kosi Challenge is just six weeks away with teams already strongly competing for the Pharma Cup.

US President Donald Trump and his Administration have announced that they will maintain the price negotiation power for prescription medicines funded through major government programs.

Sigma chair Michael Sammells said, "Whilst this model already exists in Australia and internationally, it has the potential to accelerate our strategic direction by bringing together two complementary businesses with complementary core strengths and expertise to enhance our service offering to customers."

President Donald Trump's nominee to lead the US Department of Health has denied reports suggesting he supported seizing pharmaceutical patents.

The Royal Australian College of General Practitioners is calling on the New South Wales government to provide free access to GSK's Meningococcal B vaccine, BEXSERO, for at-risk groups.

New Zealand's Pharmac has backtracked on a proposed move to a single-funded brand of hormone replacement therapy to relieve menopause symptoms.

Australian company QBiotics has announced the appointment of two experienced and senior medical executives to its leadership team.